News & Events

Want to see what we’ve been up to? Check out our latest news, events and press releases.

Press Releases

GNS Announces Abstract and Oral Poster Presentation at CTAD & ASH, 2022 Annual Conferences

GNS, the leader in the application of Causal AI and simulation and “Digital Twins” to discover new drugs, today announced two abstracts and two oral poster presentations highlighting insight from the Gemini Digital Twin models in Alzheimer’s Disease and Multiple Myeloma will be included at the Clinical Trials on Alzheimer’s Disease conference (CTAD) in San Francisco and the American Society of Hematology (ASH) in New Orleans…

read more

GNS Appoints John Maraganore as Chair of the Board

GNS, the leader in the application of Causal AI and simulation and “Digital Twins” to discover new drugs, today announced that John Maraganore, Ph.D., former founding CEO of Alnylam Pharmaceuticals, has been appointed as the new GNS Chair of the Board…

read more